The global pulmonary drug delivery technology market is projected to grow at a CAGR of approximately 5% over the next five years. This growth is driven by the rising prevalence of respiratory diseases ...

Reinventing pulmonary care medically improves early diagnosis and interdisciplinary management for complex patients with COPD and co-morbidities.

Clinical worsening also occurred less frequently with treprostinil ...

Haunted by the cystic fibrosis patients he could not help, one Iowa doctor commits his life to understanding what is broken deep inside their cells.

After false starts and incremental gains, scientists crack the problem that made breathing impossible. Will answers come fast ...

The biotech industry has delivered an upbeat performance so far in 2026 despite an uncertain macroeconomic backdrop. Strong ...

Today, Zacks Equity Research discusses Terns Pharmaceuticals TERN, ADMA Biologics ADMA, ANI Pharmaceuticals ANIP and Liqu ...

More than 80% of patients implanted with a transvenous phrenic nerve stimulation device for central sleep apnea had at least ...

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...